RWE · Data · Platforms
Building real-world evidence, without drowning in the data.
Real-world data is everywhere, but scattered and messy. Advanced digital platforms turn registries, ePRO and connected-device streams into evidence you can actually use. Here is how.
European Champion
Platinum Award 2026
Eclevar MedTech & Milo Health · xShare × EUCROF Open Call
Led by authority
Platforms plus method.
A platform does not make evidence; a method does. Ours combines the technology with the scientific rigour a reviewer expects.
Sébastien Meier
Endpoints, statistics and RWE; architect of the MILO EDC, 21 CFR Part 11 and real-time dashboards.
Charline Petitdemange
ISO 14155 study conduct, EUDAMED registration and multi-country site monitoring across Europe.
Awards, funding, accountability
Europe’s best-rated medical device CRO.
Platinum Award 2026
Top tier at the xShare × EUCROF Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at EUCROF 2026 in Amsterdam.
The announcement →Co-funded by the European Union
Selected through the xShare Open Call for clinical research innovation, Horizon Europe.
xShare results →Independently reported
Distinction confirmed by an independent third party, the CVBF, also an awardee of the xShare × EUCROF Open Call.
CVBF coverage →The problem
The bottleneck is not data, it is usable data.
Real-world data exists in abundance, but in incompatible formats and variable quality. A digital platform’s value is turning that into a compliant, analysis-ready evidence base.
01
Why RWE is hard to build
Real-world data sits in registries, electronic health records, ePRO tools and connected devices, each with its own format, coding and quality. Assembling it into an analysis-ready dataset, with provenance and governance intact, is where most real-world evidence projects stall.
02
What a good platform does
A capable platform removes the friction between raw data and evidence.
Platform capabilities
- Connecting multiple sources into one governed dataset
- Standardising and validating data as it arrives
- GDPR-compliant pseudonymisation and access control
- Analysis-ready exports with a clear audit trail
03
Where it pays off
For EU MDR, the biggest payoff is PMCF: a platform that continuously assembles real-world data makes proactive post-market evidence feasible instead of a periodic scramble. It also strengthens market-access and reimbursement dossiers that increasingly demand real-world outcomes.
04
Technology is half the answer
A platform accelerates the mechanics, but the evidence still has to be scientifically sound: the right data sources, defined endpoints and a defensible analysis. We pair the platform with the study design and biostatistics that make the output credible to a Notified Body.
RWE, made usable
From raw data to evidence.
Talk to a specialist
Struggling to turn real-world data into evidence?
Book a free scoping call. We combine the right platform with sound study design so your real-world evidence holds up for PMCF and market access.
Book a free scoping callReal-world data is not real-world evidence until someone builds it.
An expert read pairs the right digital platform with defensible study design, turning scattered real-world data into evidence a Notified Body accepts.
Book a free scoping callQuestions we hear first